{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T15:26:47Z","timestamp":1784647607758,"version":"3.55.0"},"reference-count":11,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.kint.2025.11.007","type":"journal-article","created":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T12:33:44Z","timestamp":1770035624000},"page":"269-272","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["The many faces of cholesterol in autosomal dominant polycystic kidney disease"],"prefix":"10.1016","volume":"109","author":[{"given":"Vicente E.","family":"Torres","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2025.11.007_bib1","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.kint.2025.08.037","article-title":"A randomized controlled trial evaluated the effect of pravastatin on kidney disease outcomes in adult patients with early-stage autosomal dominant polycystic kidney disease","volume":"109","author":"Gitomer","year":"2026","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2025.11.007_bib2","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.2215\/CJN.11331114","article-title":"Pravastatin therapy and biomarker changes in children and young adults with autosomal dominant polycystic kidney disease","volume":"10","author":"Klawitter","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2025.11.007_bib3","first-page":"109","article-title":"Effect of statin therapy on the progression of autosomal dominant polycystic kidney disease. a secondary analysis of the HALT PKD trials","volume":"13","author":"Brosnahan","year":"2017","journal-title":"Curr Hypertens Rev"},{"issue":"4S","key":"10.1016\/j.kint.2025.11.007_bib4","first-page":"S117","article-title":"KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease","volume":"105","year":"2024","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2025.11.007_bib5","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s40265-025-02158-0","article-title":"Renal safety assessment of lipid-lowering drugs: between old certainties and new questions","volume":"85","author":"Tramontano","year":"2025","journal-title":"Drugs"},{"key":"10.1016\/j.kint.2025.11.007_bib6","doi-asserted-by":"crossref","DOI":"10.1172\/JCI188127","article-title":"Nonvesicular cholesterol transport in physiology","volume":"135","author":"Ferrari","year":"2025","journal-title":"J Clin Invest"},{"key":"10.1016\/j.kint.2025.11.007_bib7","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202403063","article-title":"Cholesterol ensures ciliary polycystin-2 localization to prevent polycystic kidney disease","volume":"8","author":"Itabashi","year":"2025","journal-title":"Life Sci Alliance"},{"key":"10.1016\/j.kint.2025.11.007_bib8","doi-asserted-by":"crossref","first-page":"640","DOI":"10.2215\/CJN.03250410","article-title":"Potentially modifiable factors affecting the progression of autosomal dominant polycystic kidney disease","volume":"6","author":"Torres","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2025.11.007_bib9","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.240372","article-title":"High-density lipoprotein cholesterol: how studying the 'good cholesterol' could improve cardiovascular health","volume":"15","author":"Diaz","year":"2025","journal-title":"Open Biol"},{"key":"10.1016\/j.kint.2025.11.007_bib10","doi-asserted-by":"crossref","first-page":"6468","DOI":"10.1038\/s41467-024-50318-9","article-title":"Cilia-enriched oxysterol 7\u03b2,27-DHC is required for polycystin ion channel activation","volume":"15","author":"Ha","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.kint.2025.11.007_bib11","first-page":"F791","article-title":"Coordinate regulation of 11 beta-HSD and Ke 6 genes in cpk mouse: implications for steroid metabolic defect in PKD","volume":"267","author":"Aziz","year":"1994","journal-title":"Am J Physiol"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253825009457?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253825009457?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T17:04:40Z","timestamp":1781456680000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253825009457"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":11,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S0085253825009457"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2025.11.007","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The many faces of cholesterol in autosomal dominant polycystic kidney disease","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2025.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2025.08.037","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Society of Nephrology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}